ONCOLOGY

Fecal Occult Blood Test

May 8, 2017 by in ONCOLOGY Comments Off on Fecal Occult Blood Test

7 Fecal Occult Blood Test Michel I. Kafrouni, John H. Kwon KEY POINTS • Screening with the fecal occult blood test (FOBT) is less useful in the prevention of cancer…

read more

Clinical Trials: Why Participate?

May 8, 2017 by in ONCOLOGY Comments Off on Clinical Trials: Why Participate?

18 Clinical Trials: Why Participate? Jamila Mwidau, David Chang KEY POINTS • A clinical trial is any investigation in human subjects intended to discover or verify the effects of a…

read more

Conclusion

May 8, 2017 by in ONCOLOGY Comments Off on Conclusion

22 Conclusion Susan L. Gearhart, Nita Ahuja Since 1984, death rates from colorectal cancer have decreased in both men and women, with an accelerated rate of decline after 1998. This…

read more

Preoperative Evaluation

May 8, 2017 by in ONCOLOGY Comments Off on Preoperative Evaluation

11 Preoperative Evaluation Jerry Stonemetz, Nicole A. Phillips, Susan L. Gearhart KEY POINTS • Several models for comprehensive preoperative assessment exist to assist the multidisciplinary team in the perioperative management…

read more

Hereditary Colorectal Cancer and Polyp Syndromes

May 8, 2017 by in ONCOLOGY Comments Off on Hereditary Colorectal Cancer and Polyp Syndromes

3 Hereditary Colorectal Cancer and Polyp Syndromes Francis M. Giardiello KEY POINTS • Hereditary colorectal cancer accounts for 3% to 5% of all cases of colorectal cancer. • The well-described…

read more
Get Clinical Tree app for offline access